Canlyniadau Chwilio - Zanette, Michelle

Is there a difference in regional read [(18)F]flutemetamol amyloid patterns between end-of-life subjects and those with amnestic mild cognitive impairment? gan Farrar, Gill, Molinuevo, José Luis, Zanette, Michelle

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer’s disease, subjects with amnestic mild cognitive impairment and healthy voluntee... gan Miki, Takami, Shimada, Hiroyuki, Kim, Jae-Seung, Yamamoto, Yasuji, Sugino, Masakazu, Kowa, Hisatomo, Heurling, Kerstin, Zanette, Michelle, Sherwin, Paul F., Senda, Michio

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Estimation of amyloid distribution by [(18)F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition gan Thal, Dietmar Rudolf, Beach, Thomas G., Zanette, Michelle, Lilja, Johan, Heurling, Kerstin, Chakrabarty, Aruna, Ismail, Azzam, Farrar, Gill, Buckley, Christopher, Smith, Adrian P. L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection gan Ikonomovic, Milos D., Buckley, Chris J., Heurling, Kerstin, Sherwin, Paul, Jones, Paul A., Zanette, Michelle, Mathis, Chester A., Klunk, William E., Chakrabarty, Aruna, Ironside, James, Ismail, Azzam, Smith, Colin, Thal, Dietmar R., Beach, Thomas G., Farrar, Gill, Smith, Adrian P. L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [(18)F]-Flutemetamol PET Scan Result gan Westwood, Sarah, Baird, Alison L., Hye, Abdul, Ashton, Nicholas J., Nevado-Holgado, Alejo J., Anand, Sneha N., Liu, Benjamine, Newby, Danielle, Bazenet, Chantal, Kiddle, Steven J., Ward, Malcolm, Newton, Ben, Desai, Keyur, Tan Hehir, Cristina, Zanette, Michelle, Galimberti, Daniela, Parnetti, Lucilla, Lleó, Alberto, Baker, Susan, Narayan, Vaibhav A., van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E., Visser, Pieter Jelle, Lovestone, Simon

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Performance of [(18)F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of... gan Salloway, Stephen, Gamez, Jose E., Singh, Upinder, Sadowsky, Carl H., Villena, Teresa, Sabbagh, Marwan N., Beach, Thomas G., Duara, Ranjan, Fleisher, Adam S., Frey, Kirk A., Walker, Zuzana, Hunjan, Arvinder, Escovar, Yavir M., Agronin, Marc E., Ross, Joel, Bozoki, Andrea, Akinola, Mary, Shi, Jiong, Vandenberghe, Rik, Ikonomovic, Milos D., Sherwin, Paul F., Farrar, Gill, Smith, Adrian P.L., Buckley, Christopher J., Thal, Dietmar Rudolf, Zanette, Michelle, Curtis, Craig

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment gan Wolk, David A., Sadowsky, Carl, Safirstein, Beth, Rinne, Juha O., Duara, Ranjan, Perry, Richard, Agronin, Marc, Gamez, Jose, Shi, Jiong, Ivanoiu, Adrian, Minthon, Lennart, Walker, Zuzana, Hasselbalch, Steen, Holmes, Clive, Sabbagh, Marwan, Albert, Marilyn, Fleisher, Adam, Loughlin, Paul, Triau, Eric, Frey, Kirk, Høgh, Peter, Bozoki, Andrea, Bullock, Roger, Salmon, Eric, Farrar, Gillian, Buckley, Christopher J., Zanette, Michelle, Sherwin, Paul F., Cherubini, Andrea, Inglis, Fraser

Cael y testun llawn Cael y testun llawn Cael y testun llawn